A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and MethylprednisoloneJames R. Berenson, Robert Vescio, Stephanie R. Rice et al.|Targeted Oncology|2024Cited by 2